Search

everythinglearnresearchcommunity

for

Search:↓

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Certain natural ingredients and lifestyle changes can help manage PCOS symptoms by balancing hormones and improving insulin sensitivity.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

APKH in young males may signal early hair loss and needs early attention.

Hair follicle size is mainly influenced by the number of cells and extracellular matrix volume, with cell number having a larger impact.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Current research explores hair growth drugs, while future research aims for personalized treatments.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Blocking testosterone speeds up wound healing in males.

Low iron levels may be linked to some types of hair loss in women.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.